Home » BAXTER AND JERINI ADVANCE PROGRAM TO DEVELOP NON-INTRAVENOUS HEMOPHILIA THERAPY
BAXTER AND JERINI ADVANCE PROGRAM TO DEVELOP NON-INTRAVENOUS HEMOPHILIA THERAPY
Baxter AG and Jerini AG today announced progress in their collaborative research program to develop a non-intravenous therapy for the treatment of hemophilia. Extensive in vitro and in vivo analysis has identified several synthetic lead molecules with promising pharmacological properties.
Medical News Today (http://www.medicalnewstoday.com/medicalnews.php?newsid=45544)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May